Everest Organics Q2 FY 2025-26 Financial Results Reveal Profit Growth and Increased Sales

Everest Organics Limited has announced its unaudited financial results for Q2 and half year ended on September 30, 2025, as approved in a recent Board Meeting. The company reported a growth in profit and increased sales compared to the corresponding periods of the previous fiscal year. The revenue from operations for Q2 2025-26 stood at Rs. 6,12,015 Lakhs, marking an increase from Rs. 4,40,472 Lakhs in Q2 2024-25. The total comprehensive income for the period attributable to shareholders of the company was Rs. 11,659 Lakhs, compared to Rs. 14,062 Lakhs in the same period last year. Everest Organics operates in the Active Pharmaceutical Ingredients (API) and their Intermediates segment. The company's financial statements have been prepared in accordance with the Companies Act, 2013, and other applicable accounting principles.